Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-remifentanil vs ketofol in electroconvulsive therapy
IRCT20160307026950N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of propofol, remifentanil and ketamine in seizure (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Seizure duration. Started Mar 2018; status: completed.
02
Drugs
propofolremifentanilketamine
03
Conditions
seizure
Beyond the preview
Go deeper on IRCT20160307026950N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N9.